PBK Expression Promotes the Aggressive Phenotypes of Mesothelioma

Kazumi Hori1, Ichidai Tanaka1, Tatsuhiro Sato2

  • 1Department of Respiratory Medicine Nagoya University Graduate School of Medicine, Nagoya, Japan.

Cancer Science
|June 25, 2025
PubMed
Summary

PDZ-binding kinase (PBK) drives mesothelioma aggressiveness. Targeting PBK may offer new therapeutic strategies and improve patient prognosis for this aggressive cancer.